Accessibility disclaimer: To obtain information contained in document files on this page in an accessible format please contact the IU Human Research Protection Program (HRPP) at (317) 274-8289 or via email at irb@iu.edu
Seeking Opinion from FDA Regarding Drug Exemption
Seeking FDA opinion on drug exemptions
- Last updated:
- 09/11/2018
- Guidance Contact:
IU Human Research Protection Program (HRPP)
irb@iu.edu
For research involving drugs, investigators should make an initial determination whether the use of the drug in the research requires an IND application, or whether the use may be exempt from the IND requirements. For more information about this determination, and how to request advice from the FDA regarding IND exemption, visit the FDA website on IND Application Procedures: Exemptions from IND Requirements.
Consider using the following template when seeking an opinion from the FDA regarding potential IND-exempt status:
FDA Opinion Letter (Accessible 07/03/19)
For further information regarding drug and device development, please contact the Indiana Clinical Translational Sciences Institute (CTSI) at: info@indianactsi.org.